======= MSL3 =======
== Gene Information ==
* **Official Symbol**: MSL3
* **Official Name**: MSL complex subunit 3
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10943|10943]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8N5Y2|Q8N5Y2]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=MSL3&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MSL3|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/300609|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a nuclear protein that is similar to the product of the Drosophila male-specific lethal-3 gene. The Drosophila protein plays a critical role in a dosage-compensation pathway, which equalizes X-linked gene expression in males and females. Thus, the human protein is thought to play a similar function in chromatin remodeling and transcriptional regulation, and it has been found as part of a complex that is responsible for histone H4 lysine-16 acetylation. This gene can undergo X inactivation. Alternative splicing results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 2, 7 and 8. [provided by RefSeq, Jul 2010].
* **UniProt Summary**: May be involved in chromatin remodeling and transcriptional regulation. May have a role in X inactivation. Component of the MSL complex which is responsible for the majority of histone H4 acetylation at 'Lys-16' which is implicated in the formation of higher-order chromatin structure. Specifically recognizes histone H4 monomethylated at 'Lys-20' (H4K20Me1) in a DNA-dependent manner and is proposed to be involved in chromosomal targeting of the MSL complex. {ECO:0000269|PubMed:16227571, ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:20657587, ECO:0000269|PubMed:20943666, ECO:0000269|PubMed:21217699, ECO:0000269|PubMed:22547026}.
|MRG|
|Tudor-knot|
|MSL complex|
|histone H2A acetylation|
|NuA4 histone acetyltransferase complex|
|histone H4-K16 acetylation|
|histone acetyltransferase complex|
|histone deacetylation|
|protein deacetylation|
|histone H4 acetylation|
|chromatin organization involved in negative regulation of transcription|
|chromatin silencing|
|methylated histone binding|
|protein deacylation|
|macromolecule deacylation|
|chromatin organization involved in regulation of transcription|
|negative regulation of gene expression, epigenetic|
|histone acetylation|
|internal peptidyl-lysine acetylation|
|peptidyl-lysine acetylation|
|internal protein amino acid acetylation|
|protein acetylation|
|gene silencing|
|protein acylation|
|regulation of gene expression, epigenetic|
|peptidyl-lysine modification|
|histone modification|
|covalent chromatin modification|
|chromatin organization|
|peptidyl-amino acid modification|
|chromosome organization|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|DNA binding|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|negative regulation of gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|-2.28|
|[[:results:exp512|Olaparib 4μM R08 exp512]]|-2.26|
|[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-2.08|
|[[:results:exp525|Sulforaphane 9μM R08 exp525]]|-1.97|
|[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-1.97|
|[[:results:exp436|Dynasore 7μM R08 exp436]]|-1.91|
|[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|-1.91|
|[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-1.85|
|[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|-1.83|
|[[:results:exp330|5-Azacytidine 2μM R07 exp330]]|-1.81|
|[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|-1.8|
|[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|-1.78|
|[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-1.76|
|[[:results:exp85|UM0129480 7μM R02 exp85]]|-1.75|
|[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|-1.74|
|[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|-1.73|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/683
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/26|
|bone|0/25|
|breast|0/30|
|central nervous system|0/49|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/11|
|fibroblast|0/1|
|gastric|0/14|
|kidney|0/18|
|liver|0/19|
|lung|0/72|
|lymphocyte|0/14|
|ovary|0/25|
|pancreas|0/22|
|peripheral nervous system|0/15|
|plasma cell|0/12|
|prostate|0/1|
|skin|0/20|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/28|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 2273
* **Expression level (log2 read counts)**: 5.55
{{:chemogenomics:nalm6 dist.png?nolink |}}